PHS
ACOR
PFM Health Sciences’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,526,174
| Closed | -$1.42M | – | 84 |
|
|
2020
Q1 | $1.42M | Sell |
1,526,174
-367,226
| -19% | -$342K | 0.12% | 59 |
|
|
2019
Q4 | $3.86M | Sell |
1,893,400
-292,857
| -13% | -$598K | 0.18% | 52 |
|
|
2019
Q3 | $6.28M | Buy |
+2,186,257
| New | +$6.27M | 0.19% | 61 |
|
|
2019
Q1 | – | Sell |
-1,108,659
| Closed | -$17.3M | – | 116 |
|
|
2018
Q4 | $17.3M | Sell |
1,108,659
-138,775
| -11% | -$2.16M | 0.46% | 58 |
|
|
2018
Q3 | $24.5M | Sell |
1,247,434
-913,230
| -42% | -$17.9M | 0.36% | 76 |
|
|
2018
Q2 | $62M | Sell |
2,160,664
-1,194,520
| -36% | -$34.3M | 0.97% | 32 |
|
|
2018
Q1 | $79.4M | Sell |
3,355,184
-96,369
| -3% | -$2.28M | 1.61% | 20 |
|
|
2017
Q4 | $74M | Sell |
3,451,553
-600,736
| -15% | -$12.9M | 1.76% | 17 |
|
|
2017
Q3 | $95.8M | Buy |
4,052,289
+1,464,132
| +57% | +$34.6M | 1.88% | 11 |
|
|
2017
Q2 | $51M | Buy |
+2,588,157
| New | +$51M | 1.37% | 27 |
|
|
2016
Q2 | – | Sell |
-478,268
| Closed | -$12.7M | – | 99 |
|
|
2016
Q1 | $12.7M | Sell |
478,268
-809,175
| -63% | -$21.4M | 0.39% | 54 |
|
|
2015
Q4 | $55.1M | Buy |
1,287,443
+373,769
| +41% | +$16M | 1.67% | 24 |
|
|
2015
Q3 | $24.2M | Buy |
913,674
+96,278
| +12% | +$2.55M | 0.68% | 46 |
|
|
2015
Q2 | $27.2M | Buy |
817,396
+352,098
| +76% | +$11.7M | 0.69% | 47 |
|
|
2015
Q1 | $15.5M | Sell |
465,298
-407,469
| -47% | -$13.6M | 0.43% | 63 |
|
|
2014
Q4 | $35.7M | Sell |
872,767
-353,310
| -29% | -$14.4M | 0.83% | 40 |
|
|
2014
Q3 | $41.5M | Buy |
+1,226,077
| New | +$41.5M | 0.96% | 32 |
|
|
2014
Q2 | – | Sell |
-723,621
| Closed | -$27.4M | – | 82 |
|
|
2014
Q1 | $27.4M | Buy |
+723,621
| New | +$27.4M | 0.5% | 50 |
|